Anna Ribera

Presence of the Tet M Determinant in a Clinical Isolate of <i>Acinetobacter baumannii</i>

Anna Ribera, Jordi Vilà · Antimicrobial Agents and Chemotherapy · 2003 · 59 citations · Full text

Life Sciences, Microbiology, Molecular Genetics +17

High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae

J. Munoz- Gomez, Margarita M. Navia, Anna Ribera et al. · Diagnostic Microbiology and Infectious Disease · 2002 · 46 citations

Life Sciences, Infectious Diseases, Microbiology +16

Mutations in <i>gyrA</i> and <i>parC</i> QRDRs Are Not Relevant for Quinolone Resistance in Epidemiological Unrelated <i>Stenotrophomonas maltophilia</i> Clinical Isolates

Anna Ribera, Antonio Doménech‐Sánchez, Vicente J. Benedí et al. · Microbial Drug Resistance · 2002 · 42 citations

Life Sciences, Infectious Diseases, Microbiology +16

Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii

Margarita M. Navia, Anna Ribera, Maria T. Jimenez de Anta et al. · Journal of Antimicrobial Chemotherapy · 1999 · 30 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine

Anna Ribera, A. Jurado, Francesc Marco et al. · Diagnostic Microbiology and Infectious Disease · 2002 · 26 citations

Medicine, Infectious Diseases, Pharmacology +7